Molecule Name |
DB00210
|
DrugBank Groups |
Approved
|
Cluster No |
76
|
Smiles |
O=C(O)C6(=CC=5(C(=CC(C1(=CC(=C(OC)C=C1)C23(CC4(CC(C2)CC(C3)C4))))=CC=5)C=C6))
|
Download |
mol2, pdbqt
|
TPSA |
46,53
|
Non-H Atoms |
31
|
Non-C/H Atoms |
3
|
Metal-Atoms |
0
|
Electronegative Atoms |
3
|
Stereo Centers |
0
|
Rotatable Bonds |
4
|
Rings Closures |
6
|
Small Rings |
7
|
Aromatic Rings |
3
|
Aromatic Atoms |
16
|
sp3-Atoms |
13
|
Symmetric atoms |
6
|
cLogS |
-8,047
|
MW |
412,527
|
cLogP |
6,0586
|
HBA |
3
|
HBD |
1
|
Ro5 violations |
1
|
Druglikeness |
-0,92
|
DrugScore |
5,29277773396137E-02
|
Mutagenic |
high
|
Tumorigenic |
low
|
Reproductive Effective |
high
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-4,0179
|
Caco-2 Permeability 2 |
1,0951
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
0,4293
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
1,4112
|
Honey Bee Toxicity |
High HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,6913
|
Carcinogenicity (Three-class) |
Warning
|